TBCRC030: A randomized, phase II study of preoperative cisplatin versus paclitaxel in patients (pts) with BRCA1/2-proficient triple-negative breast cancer (TNBC)-Evaluating the homologous recombination deficiency (HRD) biomarker Meeting Abstract
| Authors: | Mayer, E. L.; Vaz-Luis, I.; Richardson, A. L.; Perou, C. M.; Tung, N. M.; Abramson, V. G.; Anders, C. K.; Forero-Torres, A.; Marcom, P. K.; Miller, K.; Puhalla, S.; Rimawi, M. F.; Stearns, V.; Traina, T. A.; Barry, W. T.; Jones, J. T.; Timms, K.; Hartman, A. R.; Wolff, A. C.; Winer, E. P. |
| Abstract Title: | TBCRC030: A randomized, phase II study of preoperative cisplatin versus paclitaxel in patients (pts) with BRCA1/2-proficient triple-negative breast cancer (TNBC)-Evaluating the homologous recombination deficiency (HRD) biomarker |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202008 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.tps1145 |
| Notes: | Meeting Abstract: TPS1145 -- Source: Wos |
